alexa Stephen F. Amato | Northeastern University
[Jurnalul de Chirurgie]
ISSN: 1584-9341

Journal of Surgery
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
 
 

Stephen F. Amato

Stephen F. Amato Stephen F. AMATO
Senior Faculty Member

Biomedical Regulatory Affairs Program
College of Professional Studies
Northeastern University, USA
Biography

Dr. Stephen F. Amato has over 20 years of experience in the pharmaceutical, biotechnology and medical device industries.  He is a Senior Faculty Member of the Biomedical Regulatory Affairs Program in the College of Professional Studies at Northeastern University.  Steve is also the Managing Director of tJun 17 Life Sciences, LLC, an organization that facilitates the global commercialization of early stage medical technologies.  Prior to founding tJun 17 Life Sciences, Steve was an Executive Director at Anika Therapeutics where he served as the Head of Anikas Marketing Department.  In this role he managed all aspects of the companys product portfolio including market segmentation, targeting, positioning, pricing and promotional strategies.  From 2000 to 2007 he was the Group Director of Knee Repair at Smith & Nephew Endoscopy where he managed a $140 M orthopedic product portfolio.   Earlier in his career, Steve worked for Visible Genetics, where he was responsible for developing and launching genomic molecular diagnostics products used for subtyping Human Papilloma Virus (HPV) and other infectious disease agents.  He has also worked with Critical Therapeutics on the development and commercialization of treatments for gram-negative sepsis.
Dr. Amato holds an AB in Biochemical Sciences from Harvard University, a Ph.D. in Molecular and Cellular Biology from Boston College’s Graduate School of Arts & Sciences, and an MBA from the Carroll School of Graduate Management at Boston College.  He has received the US Regulatory Affairs Certification (RAC) designation and is a Consultant for the Regulatory Affairs Professional Society (RAPS).

Research Interest

Visible Genetics, Genomic Molecular Diagnostics Products, Critical Therapeutics, Molecular and Cellular Biology, Regulatory Affairs

Certificate
Certificate

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords